Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara L Lin

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Annals of Hematology|September 13, 2023
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemiaPeter J P Croucher, Maya Ridinger, Pamela S Becker, et al.
Cancer Medicine|January 27, 2015
Rates of complete diagnostic testing for patients with acute myeloid leukemiaTara L Lin, Travis Williams, Jianghua He, et al.
British Journal of Haematology|April 19, 2012
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialChung-Gi Lee, Bikul Das, Tara L Lin, et al.
Research Square|May 3, 2024
Evaluating the impact of delayed study startup on accrual in cancer studiesIsuru Ratnayake, Anh-Tuan Do, Daniel Gajewski, et al.
Blood Advances|April 20, 2022
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AMLGeoffrey L Uy, Laura F Newell, Tara L Lin, et al.
Contemporary Clinical Trials Communications|November 10, 2025
Evaluating the impact of delayed study startup on accrual in cancer studiesIsuru Ratnayake, Anh-Tuan Do, Daniel Gajewski, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2015
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weightWhitney M Bray, Cory Bivona, Michelle Rockey, et al.
Leukemia & Lymphoma|April 10, 2013
A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cellsOmar S Aljitawi, Dandan Li, Yinghua Xiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell TransplantationCynthia Obiozor, Dipti P Subramaniam, Clint Divine, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Annals of Hematology|September 13, 2023
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemiaPeter J P Croucher, Maya Ridinger, Pamela S Becker, et al.
Cancer Medicine|January 27, 2015
Rates of complete diagnostic testing for patients with acute myeloid leukemiaTara L Lin, Travis Williams, Jianghua He, et al.
British Journal of Haematology|April 19, 2012
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialChung-Gi Lee, Bikul Das, Tara L Lin, et al.
Research Square|May 3, 2024
Evaluating the impact of delayed study startup on accrual in cancer studiesIsuru Ratnayake, Anh-Tuan Do, Daniel Gajewski, et al.
Blood Advances|April 20, 2022
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AMLGeoffrey L Uy, Laura F Newell, Tara L Lin, et al.
Contemporary Clinical Trials Communications|November 10, 2025
Evaluating the impact of delayed study startup on accrual in cancer studiesIsuru Ratnayake, Anh-Tuan Do, Daniel Gajewski, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2015
Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weightWhitney M Bray, Cory Bivona, Michelle Rockey, et al.
Leukemia & Lymphoma|April 10, 2013
A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cellsOmar S Aljitawi, Dandan Li, Yinghua Xiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell TransplantationCynthia Obiozor, Dipti P Subramaniam, Clint Divine, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Pageof 9